Clinical Trials Directory

Trials / Sponsors / Cellectar Biosciences, Inc.

Cellectar Biosciences, Inc.

Industry · 12 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingPhase 1 Study of CLR 125 in Triple Negative Breast Cancer
Breast Cancer
Phase 12025-12-05
Active Not RecruitingNovel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG
High-Grade Glioma
Phase 12023-10-01
Active Not RecruitingDose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and
Pediatric Solid Tumor, Pediatric Lymphoma, Pediatric Brain Tumor
Phase 12019-04-30
Active Not RecruitingStudy of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom
Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia
Phase 22017-07-26
CompletedDose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 12015-02-01
WithdrawnOpen-Label Study of I-131-CLR1404 in Subjects With Recurrent Glioma
Glioma
Phase 22014-05-01
TerminatedImaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
Glioblastoma
Phase 22014-02-01
CompletedDose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Retur
Cancer
Phase 12011-12-01
CompletedA Trial of NOV-205 in Hepatitis C Patients Who Failed Standard Therapy
Hepatitis C
Phase 22010-03-01
CompletedStudy of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer
Non Small Cell Lung Cancer
Phase 32006-11-01
CompletedSafety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard Therapy
Hepatitis C
Phase 12006-08-01
CompletedEfficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian Cancer
Ovarian Cancer
Phase 22006-07-01